Cargando…
Aminoglycosides for the Treatment of Severe Infection Due to Resistant Gram-Negative Pathogens
Aminoglycosides are a family of rapidly bactericidal antibiotics that often remain active against resistant Gram-negative bacterial infections. Over the past decade, their use in critically ill patients has been refined; however, due to their renal and cochleovestibular toxicity, their indications i...
Autores principales: | Thy, Michaël, Timsit, Jean-François, de Montmollin, Etienne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215420/ https://www.ncbi.nlm.nih.gov/pubmed/37237763 http://dx.doi.org/10.3390/antibiotics12050860 |
Ejemplares similares
-
Treatment of Severe Infections Due to Metallo-Betalactamases Enterobacterales in Critically Ill Patients
por: Timsit, Jean-François, et al.
Publicado: (2022) -
Cefiderocol Treatment for Severe Infections due to Difficult-to-Treat-Resistant Non-Fermentative Gram-Negative Bacilli in ICU Patients: A Case Series and Narrative Literature Review
por: Wicky, Paul-Henri, et al.
Publicado: (2023) -
Therapy of Infections due to Carbapenem-Resistant Gram-Negative Pathogens
por: Lee, Chang-Seop, et al.
Publicado: (2014) -
Spectrum of Aminoglycoside Modifying Enzymes in Gram-Negative Bacteria Causing Human Infections
por: Lalitha Aishwarya, Kayanam Vijaya, et al.
Publicado: (2020) -
Aminoglycoside Resistance Rates, Phenotypes, and Mechanisms of Gram-Negative Bacteria from Infected Patients in Upper Egypt
por: Gad, Gamal F., et al.
Publicado: (2011)